File Download

There are no files associated with this item.

Supplementary

Conference Paper: Treatment evaluation, treatment eligibility, and antiviral therapy among Asian and non-Asian patients with chronic hepatitis B (CHB)

TitleTreatment evaluation, treatment eligibility, and antiviral therapy among Asian and non-Asian patients with chronic hepatitis B (CHB)
Authors
Huang, DNguyen, VHTrinh, H-NOgawa, EEnomoto, MKozuka, RMarciano, SSuzuki, TYoshimaru, YKo, KLHUI, WHRLee, DHGo, MSLee, CPreda, CMQuek, SKhine, HHTWTakahashi, HInoue, KMaeda, MHoang, JKudaravalli, STrinh, LChau, ALi, JZhang, JQWong, CCheung, RCYuen, RMFTanaka, YGadano, ALim, SGNguyen, MH
Issue Date2021
Citation
Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology, v. 74 n. S1, p. 467A-468A How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/319386

 

DC FieldValueLanguage
dc.contributor.authorHuang, D-
dc.contributor.authorNguyen, VH-
dc.contributor.authorTrinh, H-N-
dc.contributor.authorOgawa, E-
dc.contributor.authorEnomoto, M-
dc.contributor.authorKozuka, R-
dc.contributor.authorMarciano, S-
dc.contributor.authorSuzuki, T-
dc.contributor.authorYoshimaru, Y-
dc.contributor.authorKo, KL-
dc.contributor.authorHUI, WHR-
dc.contributor.authorLee, DH-
dc.contributor.authorGo, MS-
dc.contributor.authorLee, C-
dc.contributor.authorPreda, CM-
dc.contributor.authorQuek, S-
dc.contributor.authorKhine, HHTW-
dc.contributor.authorTakahashi, H-
dc.contributor.authorInoue, K-
dc.contributor.authorMaeda, M-
dc.contributor.authorHoang, J-
dc.contributor.authorKudaravalli, S-
dc.contributor.authorTrinh, L-
dc.contributor.authorChau, A-
dc.contributor.authorLi, J-
dc.contributor.authorZhang, JQ-
dc.contributor.authorWong, C-
dc.contributor.authorCheung, RC-
dc.contributor.authorYuen, RMF-
dc.contributor.authorTanaka, Y-
dc.contributor.authorGadano, A-
dc.contributor.authorLim, SG-
dc.contributor.authorNguyen, MH-
dc.date.accessioned2022-10-14T05:12:22Z-
dc.date.available2022-10-14T05:12:22Z-
dc.date.issued2021-
dc.identifier.citationPoster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology, v. 74 n. S1, p. 467A-468A-
dc.identifier.urihttp://hdl.handle.net/10722/319386-
dc.languageeng-
dc.relation.ispartofPoster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology-
dc.titleTreatment evaluation, treatment eligibility, and antiviral therapy among Asian and non-Asian patients with chronic hepatitis B (CHB)-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros338525-
dc.identifier.volume74-
dc.identifier.issueS1-
dc.identifier.spage467A-
dc.identifier.epage468A-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats